BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38769091)

  • 1. Downregulation of miR-181c-5p in Alzheimer's disease weakens the response of microglia to Aβ phagocytosis.
    Li R; Yao S; Wei F; Chen M; Zhong Y; Zou C; Chen L; Wei L; Yang C; Zhang X; Liu Y
    Sci Rep; 2024 May; 14(1):11487. PubMed ID: 38769091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
    Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
    J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181c-5p suppresses neuronal pyroptosis via NLRP1 in Alzheimer's disease.
    Wang T; Long Q; Hu Y; Yang Y; Li X; Wei H
    Behav Brain Res; 2023 Jun; 447():114387. PubMed ID: 37003492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.
    Wan W; Liu G; Li X; Liu Y; Wang Y; Pan H; Hu J
    Bioengineered; 2021 Dec; 12(2):12678-12690. PubMed ID: 34818971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircPTK2-miR-181c-5p-HMGB1: a new regulatory pathway for microglia activation and hippocampal neuronal apoptosis induced by sepsis.
    Li M; Hu J; Peng Y; Li J; Ren R
    Mol Med; 2021 May; 27(1):45. PubMed ID: 33952191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of miR-34a by Inhibition of IRE1
    Li Q; Liu T; Yang S; Zhang Z
    Oxid Med Cell Longev; 2019; 2019():2140427. PubMed ID: 31281568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1.
    Zhu M; Jia L; Jia J
    J Alzheimers Dis; 2021; 83(1):367-377. PubMed ID: 34334400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircAXL Knockdown Alleviates Aβ
    Meng S; Wang B; Li W
    Neurochem Res; 2022 Jun; 47(6):1707-1720. PubMed ID: 35229272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.
    Li Q; Li X; Wang L; Zhang Y; Chen L
    J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice.
    Li Q; Peng J; Luo Y; Zhou J; Li T; Cao L; Peng S; Zuo Z; Wang Z
    J Neuroinflammation; 2022 Jun; 19(1):145. PubMed ID: 35701825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
    Ma X; Zhang Y; Gou D; Ma J; Du J; Wang C; Li S; Cui H
    J Alzheimers Dis; 2022; 88(2):771-785. PubMed ID: 35694923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
    Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
    Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic transcripts of LINC01311 and hsa-miR-146a-5p regulate neural development in a cellular model of Alzheimer's disease.
    Fan Y; Zhang J; Zhuang X; Geng F; Jiang G; Yang X
    IUBMB Life; 2021 Jul; 73(7):916-926. PubMed ID: 33830627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-107-5p ameliorates neurological damage, oxidative stress, and immune responses in mice with Alzheimer's disease by suppressing the Toll-like receptor 4 (TLR4)/nuclear factor-kappaB(NF-κB) pathway.
    Hu GJ; Jiang XY; Du SY; Zhang K; Chen Z
    Kaohsiung J Med Sci; 2024 Feb; 40(2):119-130. PubMed ID: 38305705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1].
    Zhou H; Zhou L; Zhang C; Zhou L; Han Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
    Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
    Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease.
    Cieślik M; Czapski GA; Wójtowicz S; Wieczorek I; Wencel PL; Strosznajder RP; Jaber V; Lukiw WJ; Strosznajder JB
    Mol Neurobiol; 2020 Mar; 57(3):1374-1388. PubMed ID: 31734880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease.
    Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R
    Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.